We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JELD icon
1676
JELD-WEN Holding
JELD
$164M
$2.95M ﹤0.01%
111,778
+6,347
+6% +$165K
AAMI
1677
Acadian Asset Management
AAMI
$3.19B
$2.94M ﹤0.01%
114,956
-29,439
-20% -$828K
SMP icon
1678
Standard Motor Products
SMP
$911M
$2.94M ﹤0.01%
56,164
-681
-1% -$34.2K
TILE icon
1679
Interface
TILE
$2.22B
$2.94M ﹤0.01%
184,376
-3,849
-2% -$59.8K
BRSL
1680
Brightstar Lottery PLC
BRSL
$2.03B
$2.94M ﹤0.01%
101,624
-1,313
-1% -$37.2K
ETWO
1681
DELISTED
E2open Parent Holdings
ETWO
$2.94M ﹤0.01%
260,816
+40,840
+19% +$480K
FTDR icon
1682
Frontdoor
FTDR
$6.26B
$2.94M ﹤0.01%
80,147
+1,182
+1% +$44.9K
KRTX
1683
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.94M ﹤0.01%
22,411
-239
-1% -$30.9K
DCH
1684
Dauch Corp
DCH
$1.51B
$2.93M ﹤0.01%
314,005
-568
-0.2% -$5.43K
WNC icon
1685
Wabash National
WNC
$527M
$2.93M ﹤0.01%
150,043
-902
-0.6% -$15.7K
GEO icon
1686
The GEO Group
GEO
$4.04B
$2.92M ﹤0.01%
377,286
-1,396
-0.4% -$11.4K
USNA icon
1687
Usana Health Sciences
USNA
$286M
$2.92M ﹤0.01%
28,885
-850
-3% -$84.8K
ANGO icon
1688
AngioDynamics
ANGO
$649M
$2.92M ﹤0.01%
105,867
-3,931
-4% -$108K
LESL icon
1689
Leslie's
LESL
$11M
$2.92M ﹤0.01%
6,162
+994
+19% +$429K
NVRO
1690
DELISTED
NEVRO CORP.
NVRO
$2.91M ﹤0.01%
35,926
-676
-2% -$67.7K
CWK icon
1691
Cushman & Wakefield Ltd
CWK
$3.25B
$2.91M ﹤0.01%
130,910
-95
-0.1% -$1.84K
DNOW icon
1692
DNOW Inc
DNOW
$2.99B
$2.91M ﹤0.01%
340,904
+5,036
+1% +$43.7K
GCO icon
1693
Genesco
GCO
$422M
$2.9M ﹤0.01%
45,253
-1,040
-2% -$66K
ADPT icon
1694
Adaptive Biotechnologies
ADPT
$3.97B
$2.9M ﹤0.01%
103,228
+4,739
+5% +$145K
CHCT
1695
Community Healthcare Trust
CHCT
$454M
$2.89M ﹤0.01%
61,168
+1,614
+3% +$74.1K
PBI icon
1696
Pitney Bowes
PBI
$2.39B
$2.88M ﹤0.01%
433,679
-842
-0.2% -$5.97K
IHRT icon
1697
iHeartMedia
IHRT
$583M
$2.87M ﹤0.01%
136,492
-1,929
-1% -$40.9K
BHE icon
1698
Benchmark Electronics
BHE
$2.96B
$2.86M ﹤0.01%
105,576
-1,111
-1% -$28.5K
SWCH
1699
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$2.86M ﹤0.01%
99,752
+1,642
+2% +$42.9K
ICFI icon
1700
ICF International
ICFI
$1.72B
$2.85M ﹤0.01%
27,752
-424
-2% -$42.7K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.